166 related articles for article (PubMed ID: 28786219)
1. Rectal protection in prostate stereotactic radiotherapy: a retrospective exploratory analysis of two rectal displacement devices.
Wilton L; Richardson M; Keats S; Legge K; Hanlon MC; Arumugam S; Hunter P; Evans TJ; Sidhom M; Martin J
J Med Radiat Sci; 2017 Dec; 64(4):266-273. PubMed ID: 28786219
[TBL] [Abstract][Full Text] [Related]
2. Improved rectal dosimetry with the use of SpaceOAR during high-dose-rate brachytherapy.
Wu SY; Boreta L; Wu A; Cheung JP; Cunha JAM; Shinohara K; Chang AJ
Brachytherapy; 2018; 17(2):259-264. PubMed ID: 29203149
[TBL] [Abstract][Full Text] [Related]
3. SpaceOAR hydrogel spacer injection prior to stereotactic body radiation therapy for men with localized prostate cancer: A systematic review.
Payne HA; Pinkawa M; Peedell C; Bhattacharyya SK; Woodward E; Miller LE
Medicine (Baltimore); 2021 Dec; 100(49):e28111. PubMed ID: 34889268
[TBL] [Abstract][Full Text] [Related]
4. Real-time in vivo rectal wall dosimetry using MOSkin detectors during linac based stereotactic radiotherapy with rectal displacement.
Legge K; Greer PB; O'Connor DJ; Wilton L; Richardson M; Hunter P; Wilfert A; Martin J; Rosenfeld A; Cutajar D
Radiat Oncol; 2017 Feb; 12(1):41. PubMed ID: 28241841
[TBL] [Abstract][Full Text] [Related]
5. A novel model to correlate hydrogel spacer placement, perirectal space creation, and rectum dosimetry in prostate stereotactic body radiotherapy.
Hwang ME; Black PJ; Elliston CD; Wolthuis BA; Smith DR; Wu CC; Wenske S; Deutsch I
Radiat Oncol; 2018 Oct; 13(1):192. PubMed ID: 30285812
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of and rectal dosimetry improvement with the use of SpaceOAR® hydrogel for dose-escalated prostate cancer radiotherapy.
van Gysen K; Kneebone A; Alfieri F; Guo L; Eade T
J Med Imaging Radiat Oncol; 2014 Aug; 58(4):511-6. PubMed ID: 24580893
[TBL] [Abstract][Full Text] [Related]
7. Natural history of lower urinary tract symptoms among men undergoing stereotactic body radiation therapy for prostate cancer with and without a Rectal Hydrogel Spacer.
Alshak MN; Eidelberg A; Diaz SM; Stoddard MD; Formenti S; Nagar H; Kang J; Chughtai B
World J Urol; 2022 May; 40(5):1143-1150. PubMed ID: 35182206
[TBL] [Abstract][Full Text] [Related]
8. SpaceOAR Hydrogel in Dose-escalated Prostate Cancer Radiotherapy: Rectal Dosimetry and Late Toxicity.
Whalley D; Hruby G; Alfieri F; Kneebone A; Eade T
Clin Oncol (R Coll Radiol); 2016 Oct; 28(10):e148-54. PubMed ID: 27298241
[TBL] [Abstract][Full Text] [Related]
9. Rectal wall sparing by dosimetric effect of rectal balloon used during intensity-modulated radiation therapy (IMRT) for prostate cancer.
Teh BS; Dong L; McGary JE; Mai WY; Grant W; Butler EB
Med Dosim; 2005; 30(1):25-30. PubMed ID: 15749008
[TBL] [Abstract][Full Text] [Related]
10. Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.
Chapet O; Udrescu C; Tanguy R; Ruffion A; Fenoglietto P; Sotton MP; Devonec M; Colombel M; Jalade P; Azria D
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):425-32. PubMed ID: 24411613
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
12. Reduced motion and improved rectal dosimetry through endorectal immobilization for prostate stereotactic body radiotherapy.
de Leon J; Jameson MG; Rivest-Henault D; Keats S; Rai R; Arumugam S; Wilton L; Ngo D; Liney G; Moses D; Dowling J; Martin J; Sidhom M
Br J Radiol; 2019 Jun; 92(1098):20190056. PubMed ID: 30912956
[TBL] [Abstract][Full Text] [Related]
13. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
[TBL] [Abstract][Full Text] [Related]
14. Can a peri-rectal hydrogel spaceOAR programme for prostate cancer intensity-modulated radiotherapy be successfully implemented in a regional setting?
Te Velde BL; Westhuyzen J; Awad N; Wood M; Shakespeare TP
J Med Imaging Radiat Oncol; 2017 Aug; 61(4):528-533. PubMed ID: 28151584
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: lessons learned from prospective trials.
Jones RT; Hassan Rezaeian N; Desai NB; Lotan Y; Jia X; Hannan R; Kim DWN; Hornberger B; Dubas J; Laine AM; Zelefsky MJ; Timmerman RD; Folkert MR
Med Dosim; 2017 Winter; 42(4):341-347. PubMed ID: 28774760
[TBL] [Abstract][Full Text] [Related]
16. Real-time intrafraction prostate motion during linac based stereotactic radiotherapy with rectal displacement.
Legge K; Nguyen D; Ng JA; Wilton L; Richardson M; Booth J; Keall P; O'Connor DJ; Greer P; Martin J
J Appl Clin Med Phys; 2017 Nov; 18(6):130-136. PubMed ID: 28960696
[TBL] [Abstract][Full Text] [Related]
17. Dosimetric benefits of hemigland stereotactic body radiotherapy for prostate cancer: implications for focal therapy.
Kishan AU; Park SJ; King CR; Roberts K; Kupelian PA; Steinberg ML; Kamrava M
Br J Radiol; 2015; 88(1056):20150658. PubMed ID: 26463234
[TBL] [Abstract][Full Text] [Related]
18. [Dosimetric impact of hydrogel spacer use for stereotactic body radiotherapy of localised prostate cancer].
Ung M; Bossi A; Abbassi L; Vautier J; Anthonipillai V; Chevé M; Blanchard P
Cancer Radiother; 2021 May; 25(3):237-241. PubMed ID: 33419606
[TBL] [Abstract][Full Text] [Related]
19. Quantifying the impact of SpaceOAR hydrogel on inter-fractional rectal and bladder dose during 0.35 T MR-guided prostate adaptive radiotherapy.
Farjam R; Mahase SS; Chen SL; Coonce M; Pennell RT; Fecteau R; Chughtai B; Dewyngaert JK; Kang J; Ch Formenti S; Nagar H
J Appl Clin Med Phys; 2021 Sep; 22(9):49-58. PubMed ID: 34342134
[TBL] [Abstract][Full Text] [Related]
20. Late toxicities of prostate cancer radiotherapy with and without hydrogel SpaceAOR insertion.
Te Velde BL; Westhuyzen J; Awad N; Wood M; Shakespeare TP
J Med Imaging Radiat Oncol; 2019 Dec; 63(6):836-841. PubMed ID: 31520465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
